全文获取类型
收费全文 | 441150篇 |
免费 | 32653篇 |
国内免费 | 12219篇 |
专业分类
耳鼻咽喉 | 5955篇 |
儿科学 | 10486篇 |
妇产科学 | 8742篇 |
基础医学 | 38255篇 |
口腔科学 | 11072篇 |
临床医学 | 45023篇 |
内科学 | 53854篇 |
皮肤病学 | 6468篇 |
神经病学 | 19754篇 |
特种医学 | 12028篇 |
外国民族医学 | 153篇 |
外科学 | 58132篇 |
综合类 | 68047篇 |
现状与发展 | 34篇 |
一般理论 | 29篇 |
预防医学 | 36447篇 |
眼科学 | 5589篇 |
药学 | 35650篇 |
402篇 | |
中国医学 | 31736篇 |
肿瘤学 | 38166篇 |
出版年
2023年 | 6628篇 |
2022年 | 10085篇 |
2021年 | 17175篇 |
2020年 | 15841篇 |
2019年 | 21366篇 |
2018年 | 19018篇 |
2017年 | 16387篇 |
2016年 | 14267篇 |
2015年 | 14236篇 |
2014年 | 26638篇 |
2013年 | 27630篇 |
2012年 | 24233篇 |
2011年 | 26491篇 |
2010年 | 21282篇 |
2009年 | 19943篇 |
2008年 | 19685篇 |
2007年 | 20318篇 |
2006年 | 18206篇 |
2005年 | 15944篇 |
2004年 | 12998篇 |
2003年 | 11384篇 |
2002年 | 9120篇 |
2001年 | 8304篇 |
2000年 | 6900篇 |
1999年 | 5868篇 |
1998年 | 4911篇 |
1997年 | 4575篇 |
1996年 | 3983篇 |
1995年 | 3684篇 |
1994年 | 3501篇 |
1993年 | 2685篇 |
1992年 | 2655篇 |
1991年 | 2276篇 |
1990年 | 2064篇 |
1989年 | 1805篇 |
1988年 | 1721篇 |
1987年 | 1463篇 |
1986年 | 1339篇 |
1985年 | 4098篇 |
1984年 | 5060篇 |
1983年 | 3522篇 |
1982年 | 4017篇 |
1981年 | 3702篇 |
1980年 | 3308篇 |
1979年 | 3038篇 |
1978年 | 2635篇 |
1977年 | 1968篇 |
1976年 | 2204篇 |
1975年 | 1659篇 |
1974年 | 1439篇 |
排序方式: 共有10000条查询结果,搜索用时 187 毫秒
101.
Christopher Teng JiaDe Yu Jesse Taylor Adam I. Rubin James R. Treat 《Pediatric dermatology》2019,36(5):697-701
Erosive pustular dermatosis of the scalp (EPDS) is an uncommon chronic inflammatory response to scalp trauma that usually resolves with cicatricial alopecia. It most commonly affects elderly patients with a history of actinic damage. Herein, we describe a 16‐year‐old girl with acrofacial dysostosis type 1 presenting after surgery with crusting purulent scalp lesions, whose clinical presentation and histopathologic findings were consistent with EPDS. A review of the literature on EPDS in children is also detailed. 相似文献
102.
目的探讨接受选择性淋巴结照射(ENI)的食管鳞癌患者预后和失败模式。方法回顾性分析2005年1月至2012年12月河北医科大学第四医院收治的179例符合入组条件的食管鳞癌患者,分析肿瘤局部相关因素预测患者预后的价值,分析影响患者近期疗效、预后的影响因素,并对影响患者总生存率(OS)、无进展生存率(PFS)和复发的指标分别进行单因素和多因素分析。结果全组患者1、3、5年OS和PFS分别为77.1%、40.1%、26.0%和62.6%、30.6%、20.3%。多因素分析结果显示声音嘶哑、cN分期、cTNM分期、GTV-横径(GTV-D)和GTV-体积/长度(GTV-V/L)为影响患者OS的独立性影响因素(P<0.05);声音嘶哑、cTNM分期和近期疗效为影响患者PFS的独立性影响因素(P<0.05)。全组有75例(41.9%)患者出现复发,61例(34.1%)远处转移,其中19例(10.6%)为合并复发和远处转移。75例复发患者中64例(85.3%)患者为单纯食管复发,4例(5.3%)为单纯淋巴结复发,另7例(9.3%)患者为食管合并淋巴结复发。治疗后达完全缓解(CR)的63例患者中有18例患者出现复发,其中仅有2例患者出现淋巴结复发;logistic多因素分析结果显示患者周边组织/器官受侵、GTV-D和近期疗效为影响患者复发的独立性影响因素(P<0.05)。结论食管鳞癌患者接受ENI确实可行,其失败主要模式仍为食管复发;治疗前声音嘶哑、GTV-D和GTV-V/L较大、临床分期较晚和近期疗效不佳为患者预后较差的指标;肿瘤周边组织受侵、GTV-D和近期疗效是影响患者失败的独立性因素。 相似文献
103.
Alzheimer’s disease is characterized by the extracellular accumulation of the amyloidβin the form of amyloid plaques and the intracellular deposition of the microtubule-associated protein tau in the form of neurofibrillary tangles.Most of the Alzheimer’s drugs targeting amyloidβhave been failed in clinical trials.Particularly,tau pathology connects greatly in the pathogenesis of Alzheimer’s disease.Tau protein enhances the stabilization of microtubules that leads to the appropriate function of the neuron.Changes in the quantity or the conformation of tau protein could affect its function as a microtubules stabilizer and some of the processes wherein it is involved.The molecular mechanisms leading to the accumulation of tau are principally signified by numerous posttranslational modifications that change its conformation and structural state.Therefore,aberrant phosphorylation,as well as truncation of tau protein,has come into focus as significant mechanisms that make tau protein in a pathological entity.Furthermore,the shape-shifting nature of tau advocates to comprehend the progression of Alzheimer’s disease precisely.In this review,we emphasize the recent studies about the toxic and shape-shifting nature of tau in the pathogenesis of Alzheimer’s disease. 相似文献
104.
105.
106.
107.
108.
109.
110.
Ki-Yong An Andria R. Morielli Dong-Woo Kang Christine M. Friedenreich Donald C. McKenzie Karen Gelmon John R. Mackey Robert D. Reid Kerry S. Courneya 《International journal of cancer. Journal international du cancer》2020,146(1):150-160
The Combined Aerobic and Resistance Exercise (CARE) Trial compared different types and doses of exercise performed during breast cancer chemotherapy. Here, we report the longer-term follow-up of patient-reported outcomes, health-related fitness and exercise behavior at 6, 12 and 24 months postintervention. A multicenter trial in Canada randomized 301 breast cancer patients initiating chemotherapy to thrice weekly, supervised exercise consisting of a standard dose of 25–30 min of aerobic exercise (STAN; n = 96), a higher dose of 50–60 min of aerobic exercise (HIGH; n = 101) or a combined dose of 50–60 min of aerobic and resistance exercise (COMB; n = 104) performed for the duration of chemotherapy (median of 17 weeks). Primary outcomes were patient-reported outcomes including quality of life, cancer-related symptoms and psychosocial outcomes. Secondary outcomes were objective health-related fitness (assessed at 12 months only) and self-reported exercise behavior. A total of 269 (89.4%) participants completed patient-reported outcomes at all three follow-up time points and 263 (87.4%) completed the health-related fitness assessment at 12-month follow-up. COMB was significantly superior to (i) STAN for sleep quality at 6-month follow-up (p = 0.027); (ii) HIGH for upper body muscular endurance at 12-month follow-up (p = 0.020); and (iii) HIGH for meeting the resistance exercise guideline at 6-month follow-up (p = 0.006). Moreover, self-reported meeting of the combined exercise guideline during follow-up was significantly associated with better patient-reported outcomes and health-related fitness. Performing combined exercise during and after breast cancer chemotherapy may result in better longer-term patient-reported outcomes and health-related fitness compared to performing aerobic exercise alone. 相似文献